Renaissance Technologies LLC Invests $1.08 Million in CeriBell (NASDAQ:CBLL)

Renaissance Technologies LLC purchased a new position in CeriBell (NASDAQ:CBLL - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 41,900 shares of the company's stock, valued at approximately $1,084,000. Renaissance Technologies LLC owned approximately 0.12% of CeriBell at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Rhumbline Advisers bought a new position in shares of CeriBell in the fourth quarter worth approximately $320,000. Corebridge Financial Inc. purchased a new position in CeriBell in the 4th quarter worth approximately $158,000. PNC Financial Services Group Inc. bought a new position in CeriBell in the 4th quarter valued at approximately $47,000. Massachusetts Financial Services Co. MA purchased a new stake in CeriBell during the 4th quarter valued at $10,750,000. Finally, Vanguard Group Inc. purchased a new position in shares of CeriBell in the fourth quarter worth $18,015,000.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on CBLL shares. Canaccord Genuity Group reaffirmed a "buy" rating and set a $33.00 price objective on shares of CeriBell in a research report on Wednesday, February 26th. LADENBURG THALM/SH SH initiated coverage on shares of CeriBell in a report on Friday, April 4th. They set a "buy" rating and a $32.00 price target on the stock. Seven research analysts have rated the stock with a buy rating, According to MarketBeat, CeriBell has a consensus rating of "Buy" and an average target price of $32.50.

Insider Transactions at CeriBell

In other CeriBell news, CEO Xingjuan Chao sold 15,628 shares of the business's stock in a transaction dated Wednesday, April 23rd. The stock was sold at an average price of $15.11, for a total transaction of $236,139.08. Following the completion of the sale, the chief executive officer now owns 727,151 shares of the company's stock, valued at approximately $10,987,251.61. The trade was a 2.10 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders sold 24,700 shares of company stock worth $372,434 in the last three months.

CeriBell Stock Down 2.1 %

Shares of CeriBell stock traded down $0.33 during trading hours on Tuesday, reaching $15.85. 308,036 shares of the stock traded hands, compared to its average volume of 270,881. CeriBell has a one year low of $10.01 and a one year high of $32.75. The business's 50 day moving average is $18.51.

CeriBell (NASDAQ:CBLL - Get Free Report) last announced its earnings results on Tuesday, February 25th. The company reported ($0.40) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.32) by ($0.08). The company had revenue of $18.53 million for the quarter, compared to the consensus estimate of $17.55 million. Research analysts anticipate that CeriBell will post -2.46 EPS for the current fiscal year.

CeriBell Profile

We are a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. We have developed the Ceribell System, a novel, point-of-care electroencephalography (“EEG”) platform specifically designed to address the unmet needs of patients in the acute care setting.